2014 - Page 386 of 491 - 24/7 Wall St.

Paul Ausick | Mar 21, 2014 at 4:01 PM EDT

The 5 Stocks That Sank Markets on Friday

thinkstockMarch 21, 2014: Markets opened higher on Friday but the Nasdaq sank quickly, bounced for a while, and finally settled…

Paul Ausick | Mar 21, 2014 at 1:10 PM EDT

Visa, MasterCard Cut Service to Two Russian Banks

ThinkstockFollowing President Obama’s order on Thursday of sanctions against two dozen Russian citizens, credit card issuers Visa Inc. (NYSE: V)…

Jon C. Ogg | Mar 21, 2014 at 1:00 PM EDT

Zogenix CEO Goes on the Offensive

Zogenix has traded like a company that is about to implode. Its highly controversial Zohydro has been getting inquiries into…

Paul Ausick | Mar 21, 2014 at 12:15 PM EDT

Biopharma Firm Versartis Gets Golden IPO Treatment

Biopharmaceutical firm Versartis sold 6 million shares in a Friday morning IPO at a price higher than the estimated range.…

Paul Ausick | Mar 21, 2014 at 11:35 AM EDT

Borderfree IPO Follows Lead of Other Recent Techs: Higher

Borderfree offered 5 million shares in an initial public offering Friday morning. Shares priced at the top of their expected…

Jon C. Ogg | Mar 21, 2014 at 11:20 AM EDT

Companies That Love March Madness the Most

ThinkstockMarch Madness has arrived for you college basketball fans. What is different about March Madness, versus the Daytona 500, the…

Paul Ausick | Mar 21, 2014 at 11:05 AM EDT

Amber Road IPO Races Off the Line

Amber Road, a maker of cloud-based software for global trade management, held its initial public offering (IPO) Friday, selling 7.4…

Douglas A. McIntyre | Mar 21, 2014 at 10:56 AM EDT

Ten American Cities With the Highest Unemployment

squirrel83, via Wikimedia CommonsThe Bureau of Labor Statistics has released its data on unemployment by city for January. In general,…

Jon C. Ogg | Mar 21, 2014 at 10:30 AM EDT

Did Endocyte Just Become Buyout Bait?

Endocyte is trading like it is being acquired. This is proof that any biotech with great cancer drug news can…

Paul Ausick | Mar 21, 2014 at 10:20 AM EDT

Nike: A Time to Buy?

Since being added to the Dow Jones Industrials Index last September, shares of Nike are up just over 11%. In…

Trey Thoelcke | Mar 21, 2014 at 10:05 AM EDT

Baird Very Cautious on Energy: Six Top Stocks to Buy Now

The Baird plan of action is pretty easy for investors to follow. Keep a smaller allocation of the energy sector,…

Jon C. Ogg | Mar 21, 2014 at 9:15 AM EDT

Merrill Lynch Defends Home Depot, Says It Is Headed to $100

Bank of America Merrill Lynch is defending Home Depot. What stands out here is not just that the firm is…

Paul Ausick | Mar 21, 2014 at 9:05 AM EDT

Could Obamacare Be Working?

WellPoint raised its earnings outlook for the 2014 fiscal year, citing a benefit from the Affordable Care Act, aka Obamacare,…

Jon C. Ogg | Mar 21, 2014 at 8:55 AM EDT

Herbalife Takes Key Independent Research Analyst Downgrade

Argus has downgraded Herbalife's near-term rating to Hold from Buy. The basis for the call is the recently announced Federal…

Trey Thoelcke | Mar 21, 2014 at 8:40 AM EDT

Credit Suisse’s Top Stocks to Buy for a Difficult 2014

After a huge run, it may be time to avoid momentum stocks and focus on quality names that will not…

1 … 384 385 386 387 388 … 491

Year: 2014

The 5 Stocks That Sank Markets on Friday

Visa, MasterCard Cut Service to Two Russian Banks

Zogenix CEO Goes on the Offensive

Biopharma Firm Versartis Gets Golden IPO Treatment

Borderfree IPO Follows Lead of Other Recent Techs: Higher

Companies That Love March Madness the Most

Amber Road IPO Races Off the Line

Ten American Cities With the Highest Unemployment

Did Endocyte Just Become Buyout Bait?

Nike: A Time to Buy?

Baird Very Cautious on Energy: Six Top Stocks to Buy Now

Merrill Lynch Defends Home Depot, Says It Is Headed to $100

Could Obamacare Be Working?

Herbalife Takes Key Independent Research Analyst Downgrade

Credit Suisse’s Top Stocks to Buy for a Difficult 2014

This Stock Has Become Too Important to the AI Revolution to Ignore

Attention Alibaba Shareholders: August 20th Could Be a Very Good Day For You

Nebius Dives 14% and CoreWeave Falls 4% Before Rebounding. Neocloud Stocks Face Volatility as the Nasdaq Whipsaws.

He Worked 600 Hours of Wildfire Overtime at 64. He Thought the New Tax Break Would Protect His Social Security Check. He Was Wrong.

One December Move Erases a Year of Missed Estimated Taxes: The IRS Treats RMD Withholding as Paid On Time, All Year Long.

This Stock Has Become Too Important to the AI Revolution to Ignore

Attention Alibaba Shareholders: August 20th Could Be a Very Good Day For You

The 5 Stocks That Sank Markets on Friday

Visa, MasterCard Cut Service to Two Russian Banks

Zogenix CEO Goes on the Offensive

Biopharma Firm Versartis Gets Golden IPO Treatment

Borderfree IPO Follows Lead of Other Recent Techs: Higher

Companies That Love March Madness the Most

Amber Road IPO Races Off the Line

Ten American Cities With the Highest Unemployment

Did Endocyte Just Become Buyout Bait?

Nike: A Time to Buy?

Baird Very Cautious on Energy: Six Top Stocks to Buy Now

Merrill Lynch Defends Home Depot, Says It Is Headed to $100

Could Obamacare Be Working?

Herbalife Takes Key Independent Research Analyst Downgrade

Credit Suisse’s Top Stocks to Buy for a Difficult 2014

This Stock Has Become Too Important to the AI Revolution to Ignore

Attention Alibaba Shareholders: August 20th Could Be a Very Good Day For You

Nebius Dives 14% and CoreWeave Falls 4% Before Rebounding. Neocloud Stocks Face Volatility as the Nasdaq Whipsaws.

Featured Reads

He Worked 600 Hours of Wildfire Overtime at 64. He Thought the New Tax Break Would Protect His Social Security Check. He Was Wrong.

One December Move Erases a Year of Missed Estimated Taxes: The IRS Treats RMD Withholding as Paid On Time, All Year Long.